Ensysce Biosciences (ENSCW) Equity Ratio (2017 - 2025)

Ensysce Biosciences (ENSCW) has 9 years of Equity Ratio data on file, last reported at 0.39 in Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.39, down 35.9% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.39 (down 35.9% YoY), and the FY2025 annual result was 0.39, down 35.9% from the prior year.
• Equity Ratio climbed to 0.39 in Q4 2025 per ENSCW's latest filing, from 0.38 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.7 in Q3 2024 and troughed at 0.77 in Q3 2022.
• A 5-year average of 0.15 and a median of 0.37 in 2023 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2024: Equity Ratio slumped 1853.89% in 2022, then surged 1831.42% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.5 in 2021, then sank by 37.8% to 0.68 in 2022, then jumped by 64.88% to 0.24 in 2023, then soared by 351.1% to 0.6 in 2024, then sank by 35.9% to 0.39 in 2025.
• Business Quant data shows ENSCW's Equity Ratio at 0.39 in Q4 2025, 0.38 in Q3 2025, and 0.55 in Q2 2025.